Treatment of postpsychotic depression with sertraline in patients with schizophrenia--own experience.
Some authors treated two groups of patients with postpsychotic depression in a group of patients with schizophrenia. Sertraline proved better than imipramine in view of earlier onset of action and lower incidence, intensity and duration of adverse effects and lower risk of schizophrenic symptom recurrence.
Ros
Leszek Tomas
LT
Central University Teaching Hospital-Polyclinic, Armed Forces School of Medicine, Independent Public Health Care Institution, Department of Neurosurgery.
D000328:Adult; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012008:Recurrence; D012559:Schizophrenia / Q000150:complications; D020280:Sertraline / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D007099:Imipramine; D020280:Sertraline